Tegaserod analytical method [Regulatives / Guidelines]

posted by Ayman Rabayah – Jordan, 2020-04-08 11:23  – Posting: # 21318
Views: 502

Hello colleagues
I hope you are in good health and conditions, and wish the the COVID-19 crisis come to end in all countries.
kindly we are developing an analytical method for Tegaserod in human plasma, if you have an experience with this product (6 mg dose), is the metabolite M29 need to be included to be detected and measured, and if an LLOQ of 50 pg/ml will be enough?

looking to hear your advises
Thank you

Complete thread:

 Admin contact
20,647 posts in 4,328 threads, 1,436 registered users;
online 27 (1 registered, 26 guests [including 23 identified bots]).
Forum time: 12:56 CEST (Europe/Vienna)

A little Learning is a dang’rous Thing;
Drink deep, or taste not the Pierian Spring:
There shallow Draughts intoxicate the Brain,
And drinking largely sobers us again.    Alexander Pope

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz